Treace Medical Concepts, Inc. (TMCI) Stock

Treace Medical Concepts, Inc., a leading orthopedic medical device company based in Ponte Vedra Beach, Florida, specializes in designing, manufacturing, and marketing innovative devices tailored for foot and ankle surgeons across the United States. The company's flagship product is the Lapiplasty procedure, which enables podiatric surgeons to comprehensively address bunions in all three dimensions, resulting in both aesthetic improvement and medical benefits.

Beyond its groundbreaking Lapiplasty procedure, Treace Medical Concepts, Inc. also offers the Lapiplasty Mini-Incision precision system. This system enhances surgical precision and efficiency, further supporting surgeons in achieving optimal patient outcomes. Additionally, the company provides a range of ancillary products designed for various foot and ankle surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, and lesser tarsometatarsal joint fusions.

Treace Medical Concepts, Inc. was founded in 2013 with a clear mission to advance the field of foot and ankle surgery through innovation and technology. By focusing on the specific needs of foot and ankle surgeons, the company has established itself as a trusted partner in the orthopedic medical device industry. Its commitment to excellence in product design and surgical solutions underscores its dedication to improving patient care and surgical outcomes.

Headquartered in Florida, Treace Medical Concepts, Inc. continues to drive forward with its vision of pioneering advancements in orthopedic medical devices. Through ongoing research, development, and collaboration with healthcare professionals, the company remains at the forefront of innovation in foot and ankle surgery.